Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series
Aditya Chindam, Samanvitha Vengaldas, Vijetha Reddy Srigiri, Umair Syed, Hemanth Kilaru, Nagender Prasad Chenimilla, Satish Chandra Kilaru, Ekta Patil
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2021-08
Abstract
Non-tuberculous mycobacterial pulmonary disease (NTM-PD) may simulate Pulmonary Tuberculosis (PTB) in its clinical and radiological expression posing a diagnostic dilemma and challenge to the treating physician, especially in high TB prevalent countries. Though recent emerging data indicates inter-human transmission, infection with non-tuberculous mycobacteria (NTM) is commonly acquired from the environmental sources [1]. NTM can produce disease not only in immunocompromised populations but also in healthy individuals leading to significant morbidity and mortality [2]. Unlike PTB, NTM-PD is usually difficult to confirm and speciate in resource limited clinical settings and high TB endemic countries due to non-availability, poor accessibility and affordability to a specific culture facility. Apart from diagnostic challenges, adverse drug effects with treatment leading to non-adherence are another vexing problem. We present here case descriptions of four patients of NTM-PD, confirmed by culture isolates, one was a rapid grower and the other three were slow growers. All four patients were treated with available guideline-based treatment protocols and followed up.
MeSH terms
- Medicine
- Tuberculosis
- Intensive care medicine
- Disease
- Transmission (telecommunications)
- Culture conversion
- Nontuberculous mycobacteria
- Adverse effect
- Sputum
- Internal medicine